Back
ProShares UltraPro MidCap400 Vs. Mirum Pharmaceuticals Industry Stock Comparison
Buy
51
UMDD
ProShares UltraPro MidCap400
Last Price:
23.86
Seasonality Move:
1.02%
Buy
77
MIRM
Mirum Pharmaceuticals
Last Price:
34.15
Seasonality Move:
6.63%
Buy
51
ProShares UltraPro MidCap400 (UMDD)
is a Buy
Is ProShares UltraPro MidCap400 a Buy, Sell or Hold?
- The current ProShares UltraPro MidCap400 [UMDD] share price is $24.10. The Score for UMDD is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- UMDD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $34.19. The Score for MIRM is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UMDD Stock Price Chart
What is ProShares UltraPro MidCap400's stock price today?
-
The ProShares UltraPro MidCap400 share price today is $24.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UMDD is experiencing slight selling pressure.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $34.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing buying pressure, which is a positive indicator for future bullish movement.
UMDD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.31 | Sell |
Relative Strength Index (14 RSI): | 46.4 | Sell |
Chaikin Money Flow: | -5484 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.91 - 25.09) | Sell |
Bollinger Bands (100): | (23.24 - 26.4) | Sell |
MIRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.24 | Buy |
Relative Strength Index (14 RSI): | 66.2 | Buy |
Chaikin Money Flow: | 1534746 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.34 - 31.66) | Buy |
Bollinger Bands (100): | (24.32 - 29.22) | Buy |
UMDD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.15 | Sell |
20-day SMA: | 24.37 | Sell |
50-day SMA: | 24.79 | Sell |
200-day SMA: | 21.62 | Buy |
8-day EMA: | 24.12 | Sell |
20-day EMA: | 24.4 | Sell |
50-day EMA: | 24.68 | Sell |
200-day EMA: | 22.81 | Buy |
MIRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.57 | Buy |
20-day SMA: | 28.83 | Buy |
50-day SMA: | 26.5 | Buy |
200-day SMA: | 28.22 | Buy |
8-day EMA: | 32.4 | Buy |
20-day EMA: | 29.9 | Buy |
50-day EMA: | 27.73 | Buy |
200-day EMA: | 27.19 | Buy |
ProShares UltraPro MidCap400 Earnings Growth & UMDD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.34 per share, an increase this year of $1.92 per share, and an increase next year of $1.37 per share.
ProShares UltraPro MidCap400 Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Mirum Pharmaceuticals Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |